A case of oral fibrosarcoma in a 13-yr-old male black iguana (Ctenosaura pectinata) is reported here. The iguana exhibited new tissue formation involving a large part of the maxilla and hard palate, which histologically and ultrastructurally corresponded to a primary fibrosarcoma of the oral cavity. Although there are reports of fibrosarcomas in other reptiles, such as snakes and crocodiles, no reports of this neoplasm in the oral cavity of an iguana were reported, which suggests that it is either infrequent or infrequently sampled for histological diagnosis. As an isolated case in an adult iguana living at a conservation center, it is likely that this diagnosis is associated with advanced age. The prognosis is considered unfavorable.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1638/2012-0245R.1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Combination of Tumor-targeting A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells and .
In Vivo
December 2024
AntiCancer Inc., San Diego, CA, U.S.A.;
Background/aim: Salmonella typhimurium A1-R (A1-R) targets and inhibits a wide range of cancer types without continuously infecting healthy tissue. Chloroquine, an antimalarial drug, induces apoptosis and inhibits autophagy in cancer cells. The aim of the present study was to determine the synergy of A1-R plus chloroquine on HT1080 human fibrosarcoma cells in vitro and in a nude-mouse model.
View Article and Find Full Text PDFOn TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion-Positive Infantile Fibrosarcoma of the Head and Neck.
Head Neck
December 2024
Department of Pediatric Hematology & Oncology, Klinik für Kinder- Und Jugendmedizin, Universitätsmedizin Rostock, Rostock, Germany.
Background: Infantile fibrosarcoma (IFS) is a rare pediatric tumor of intermediate malignancy with high local aggressiveness that typically presents in young infants. Its occurrence in the head and neck region is rare. Complete non-mutilating surgical resection is often not possible, requiring multimodal treatment.
View Article and Find Full Text PDFTumor growth suppression in adoptive T cell therapy via IFN-γ targeting of tumor vascular endothelial cells.
Theranostics
December 2024
Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
In adoptive T cell therapy (ACT), the direct cytotoxic effects of CD8 T cells on tumor cells, including the release of interferon-gamma (IFN-γ), are considered the primary mechanism for tumor eradication. Cancer antigen escape diminishes the T cell responses, thereby limiting the therapeutic success. The impacts of IFN-γ targeting non-tumor cells in ACT, on the other hand, remains under-investigated.
View Article and Find Full Text PDFDifference in survival and prognosis between malignant tumors of odontogenic origin.
J Stomatol Oral Maxillofac Surg
November 2024
Sorbonne Université, Paris, France; Department of Maxillo-Facial Surgery, Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France; Sorbonne université, INSERM UMRS 938, Centre de Recherche de Saint Antoine, Team Cancer Biology and Therapeutics, France.
Introduction: The prognosis of metastatic ameloblastoma (METAM), now defined as a benign tumor, and malignant odontogenic tumors (MOT) is poorly studied in the literature. The aim of this study was to determine the prognosis and factors influencing the survival of these patients.
Material And Methods: Using the SEER database, we retrieved clinical data of patients with malignant tumors of dental origin between 1975 and 2020.
Metronomic Chemotherapy After Palliative Radiotherapy in Rare Soft Tissue Sarcomas: An Insight into Radiation Therapy and the Immune Response.
Indian J Surg Oncol
December 2024
Department of Radiation Oncology, J N Medical College, Belagavi, Karnataka India.
Article Synopsis
- Soft tissue sarcomas (STSs) make up less than 1% of all malignant tumors in humans, and treatment for metastatic STSs focuses on palliative care due to poor prognosis.
- A study evaluated the effectiveness of low-dose radiotherapy combined with metronomic therapy in 16 heavily treated patients with metastatic STSs, aiming to assess their response and quality of life.
- Results showed that 43.75% of patients achieved a partial response, and all reported improved quality of life compared to their previous treatment, demonstrating potential benefits of this combined approach in managing STSs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!